Buprenorphine HCl and Naloxone HCl
NDC 65162-416, Buprenorphine and Naloxone, tablet, from Amneal Pharmaceuticals LLC.
- Product NDC
- 65162-416
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals LLC
- Dosage form
- TABLET
- Route
- SUBLINGUAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203136
- DEA schedule
- CIII
curl https://api.healthcare.dev/v1/drugs/ndc/65162-416 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPRENORPHINE HYDROCHLORIDE2 mg/1
- NALOXONE HYDROCHLORIDE DIHYDRATE.5 mg/1
Pharmacologic classes
Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65162-416-03 | 65162041603 | 30 TABLET in 1 BOTTLE (65162-416-03) |
| 65162-416-09 | 65162041609 | 90 TABLET in 1 BOTTLE (65162-416-09) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/17b63f10-c9df-44be-80fa-6f1c305583b8NADAC price for package 65162041603
GET /v1/drugs/nadac/65162041603
Use it
Look up 65162-416 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65162-416 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65162-416. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.